Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roeland E Wasmann

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|May 14, 2023
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitisRoeland E Wasmann, Tiziana Masini, Kerri Viney, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight AdultsRoeland E Wasmann, Rob Ter Heine, Eric P van Dongen, et al.
British Journal of Clinical Pharmacology|May 23, 2022
Population pharmacokinetics of esomeprazole in patients with preterm preeclampsiaManna Semere Gebreyesus, Eric H Decloedt, Catherine A Cluver, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 4, 2023
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African populationAida N Kawuma, Roeland E Wasmann, Phumla Sinxadi, et al.
Pharmaceutical Research|January 11, 2020
Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic StudyCornelis Smit, Roeland E Wasmann, Marinus J Wiezer, et al.
Pharmaceutical Research|June 1, 2019
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic StudyCornelis Smit, Roeland E Wasmann, Marinus J Wiezer, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICsJochem B Buil, Roger J M Brüggemann, Roeland E Wasmann, et al.
The Journal of Antimicrobial Chemotherapy|November 8, 2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICsJochem B Buil, Roger J M Brüggemann, Roeland E Wasmann, et al.
American Journal of Respiratory and Critical Care Medicine|April 22, 2024
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug DosingRenu Verma, Kesia Esther da Silva, Neesha Rockwood, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosingRenu Verma, Kesia Esther da Silva, Neesha Rockwood, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|May 14, 2023
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitisRoeland E Wasmann, Tiziana Masini, Kerri Viney, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight AdultsRoeland E Wasmann, Rob Ter Heine, Eric P van Dongen, et al.
British Journal of Clinical Pharmacology|May 23, 2022
Population pharmacokinetics of esomeprazole in patients with preterm preeclampsiaManna Semere Gebreyesus, Eric H Decloedt, Catherine A Cluver, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 4, 2023
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African populationAida N Kawuma, Roeland E Wasmann, Phumla Sinxadi, et al.
Pharmaceutical Research|January 11, 2020
Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic StudyCornelis Smit, Roeland E Wasmann, Marinus J Wiezer, et al.
Pharmaceutical Research|June 1, 2019
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic StudyCornelis Smit, Roeland E Wasmann, Marinus J Wiezer, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICsJochem B Buil, Roger J M Brüggemann, Roeland E Wasmann, et al.
The Journal of Antimicrobial Chemotherapy|November 8, 2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICsJochem B Buil, Roger J M Brüggemann, Roeland E Wasmann, et al.
American Journal of Respiratory and Critical Care Medicine|April 22, 2024
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug DosingRenu Verma, Kesia Esther da Silva, Neesha Rockwood, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosingRenu Verma, Kesia Esther da Silva, Neesha Rockwood, et al.
Pageof 5